Cancer, Neurodegenerative Disease and Medicines Safety Feature in New IMI Call for Proposals

The Innovative Medicines Initiative (IMI) is launching a new Call for proposals covering diabetes, antimicrobial resistance, neurodegenerative diseases, cancer, and medicines safety during pregnancy and breastfeeding, to name just a few. The total budget of the Call is EUR 223 million, around half of which comes from the EU's Horizon 2020 programme, and half of which comes from EFPIA companies and IMI Associated Partners.
Source: eHealth News EU - Category: Information Technology Tags: Featured Open Calls Source Type: news